Newer immunology drugs Skyrizi and Rinvoq boost sales in second quarter.
You are here: Home / Top Stories / : AbbVie shares jump as results beat expectations despite blockbuster Humira’s declining sales
Market News and Views
Newer immunology drugs Skyrizi and Rinvoq boost sales in second quarter.